Analysis | Metabolite Name | Measured Value | Units | Genotype | Intestinal Segment |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M-H)- | 9194 | Peak area | FLOX | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M-H)- | 9705 | Peak area | Knockout | Duodenum |
Reversed phase NEGATIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M-H)- | Peak area | FLOX | Duodenum | |
Reversed phase NEGATIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M-H)- | Peak area | FLOX | Illeum | |
Reversed phase NEGATIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M-H)- | Peak area | FLOX | Jejunum | |
Reversed phase NEGATIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M-H)- | Peak area | Knockout | Duodenum | |
Reversed phase NEGATIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M-H)- | Peak area | Knockout | Illeum | |
Reversed phase NEGATIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M-H)- | Peak area | Knockout | Jejunum | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 2224 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 2463 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 3136 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 4436 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 5072 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 6275 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 9339 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 9648 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 9960 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 12637 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 14552 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 14878 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 16583 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 16738 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 16896 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 20177 | Peak area | FLOX | Illeum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 26580 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 34092 | Peak area | Knockout | Illeum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 35332 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 38426 | Peak area | FLOX | Jejunum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 70606 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 85688 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 241262 | Peak area | FLOX | Duodenum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 275841 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 391597 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 486022 | Peak area | Knockout | Jejunum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | 1051071 | Peak area | Knockout | Duodenum |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | FLOX | Duodenum | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | FLOX | Illeum | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | FLOX | Jejunum | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | Knockout | Duodenum | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | Knockout | Illeum | |
Reversed phase POSITIVE ION MODE | N-ALPHA-ACETYL-L-LYSINE (CAS# 1946-82-3); (M+H)+ | Peak area | Knockout | Jejunum |